InteDelta: Non-Cleared Margin Survey and Industry Overview
New regulations governing the margining of non-centrally cleared OTC derivatives are rapidly being developed by regulators. International rules were finalised by BCBS/IOSCO in September 2013. These rules will now be implemented into the regulatory frameworks of each national jurisdiction. The first jurisdiction to draft such rules was the European Union, followed by Japan. Others, in particular the US, are expected to follow.
Over the period April to June 2014, InteDelta undertook a global
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net